Back To: Home : Featured Technology : Functional Genomic Screening

CLICK HERE FOR WHAT'S NEW IN:
 

Nanobac Life Sciences, Grant D. Carlson, President and COO
04-19-2005
SHARING OPTIONS:

TAMPA, Fla.—Nanobac Life Sciences Inc. in late March the promoted Grant D. Carlson from Vice President, Business Development to President and Chief Operating Officer. Carlson now has day-to-day operational responsibility for Nanobac's in vitro diagnostics, dietary supplement, and drug discovery businesses.
 
Carlson has extensive expertise in general management, corporate and business development, product development, product launch, and sales and marketing. Prior to joining Nanobac, Carlson was vice president of marketing and business development at Agilix Corp., a functional genomics company developing gene expression and protein profiling technologies for biotechnology and pharmaceutical customers.
 
Prior to Agilix in 2001, Carlson served as vice president of marketing and business development for Dianon Systems, Inc., a leading cancer and genomic diagnostic services company. Dianon Systems was acquired by LabCorp for $598 million. During his 13 years at Dianon, Carlson held senior positions in research and development, marketing, business development, technology development and sales.
 
Under Carlson's leadership, Dianon launched over 50 advanced diagnostic products and biomarkers into clinical practice. He is co-inventor on five U.S. patents involving free-PSA and the diagnosis of prostate cancer. He has authored several scientific papers in the areas of oncology, urology and diagnostic pathology. He holds a B.S. in Kinesiology from the University of California, Los Angeles.

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.